Pharmaceutical Business review

Kingfisher receives CE Mark for wound healing device

KFH Novo utilizes Kingfisher’s Bio-Electric Stimulation Therapy to assist in and improve upon the healing of chronic wounds including venous leg ulcers, diabetic ulcers and pressure sores.

Henk Snyman, founder and CEO of Kingfisher Healthcare, said: “We are thrilled to offer physicians and patients a safe, non-invasive and cost-effective therapy designed to successfully treat several types of chronic wounds.”